Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis.

Rondon AMR, Kroone C, Kapteijn MY, Versteeg HH, Buijs JT.

Semin Thromb Hemost. 2019 Jun;45(4):396-412. doi: 10.1055/s-0039-1687895. Epub 2019 May 16.

PMID:
31096312
2.

The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice.

Buijs JT, Laghmani EH, van den Akker RFP, Tieken C, Vletter EM, van der Molen KM, Crooijmans JJ, Kroone C, Le Dévédec SE, van der Pluijm G, Versteeg HH.

J Thromb Haemost. 2019 Jun;17(6):951-963. doi: 10.1111/jth.14443. Epub 2019 Apr 29.

PMID:
30929299
4.

Pilot-scale process for magnetic bead purification of antibodies directly from non-clarified CHO cell culture.

Brechmann NA, Eriksson PO, Eriksson K, Oscarsson S, Buijs J, Shokri A, Hjälm G, Chotteau V.

Biotechnol Prog. 2019 May;35(3):e2775. doi: 10.1002/btpr.2775. Epub 2019 Jan 30.

PMID:
30629859
5.

Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties.

Deyev S, Vorobyeva A, Schulga A, Proshkina G, Güler R, Löfblom J, Mitran B, Garousi J, Altai M, Buijs J, Chernov V, Orlova A, Tolmachev V.

Mol Pharm. 2019 Mar 4;16(3):995-1008. doi: 10.1021/acs.molpharmaceut.8b00922. Epub 2019 Feb 8.

PMID:
30608701
6.

Short-term mortality in older medical emergency patients can be predicted using clinical intuition: A prospective study.

Zelis N, Mauritz AN, Kuijpers LIJ, Buijs J, de Leeuw PW, Stassen PM.

PLoS One. 2019 Jan 2;14(1):e0208741. doi: 10.1371/journal.pone.0208741. eCollection 2019.

7.

Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours.

Garousi J, Lindbo S, Borin J, von Witting E, Vorobyeva A, Oroujeni M, Mitran B, Orlova A, Buijs J, Tolmachev V, Hober S.

Eur J Pharm Biopharm. 2019 Jan;134:37-48. doi: 10.1016/j.ejpb.2018.11.004. Epub 2018 Nov 5.

8.

Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.

Navone NM, van Weerden WM, Vessella RL, Williams ED, Wang Y, Isaacs JT, Nguyen HM, Culig Z, van der Pluijm G, Rentsch CA, Marques RB, de Ridder CMA, Bubendorf L, Thalmann GN, Brennen WN, Santer FR, Moser PL, Shepherd P, Efstathiou E, Xue H, Lin D, Buijs J, Bosse T, Collins A, Maitland N, Buzza M, Kouspou M, Achtman A, Taylor RA, Risbridger G, Corey E.

Prostate. 2018 Dec;78(16):1262-1282. doi: 10.1002/pros.23701. Epub 2018 Aug 2.

PMID:
30073676
9.

Prevalence of Leptospira spp. and Seoul hantavirus in brown rats (Rattus norvegicus) in four regions in the Netherlands, 2011-2015.

Maas M, De Vries A, Reusken C, Buijs J, Goris M, Hartskeerl R, Ahmed A, Van Tulden P, Swart A, Pijnacker R, Koene M, Lundkvist Å, Heyman P, Rockx B, Van Der Giessen J.

Infect Ecol Epidemiol. 2018 Jun 26;8(1):1490135. doi: 10.1080/20008686.2018.1490135. eCollection 2018.

10.

Protocols for Migration and Invasion Studies in Prostate Cancer.

van de Merbel AF, van der Horst G, Buijs JT, van der Pluijm G.

Methods Mol Biol. 2018;1786:67-79. doi: 10.1007/978-1-4939-7845-8_4.

PMID:
29786787
11.

High prevalence rate of digestive tract bacteria in duodenoscopes: a nationwide study.

Rauwers AW, Voor In 't Holt AF, Buijs JG, de Groot W, Hansen BE, Bruno MJ, Vos MC.

Gut. 2018 Sep;67(9):1637-1645. doi: 10.1136/gutjnl-2017-315082. Epub 2018 Apr 10.

12.

Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse.

Nordling S, Brännström J, Carlsson F, Lu B, Salvaris E, Wanders A, Buijs J, Estrada S, Tolmachev V, Cowan PJ, Lorant T, Magnusson PU.

Sci Rep. 2018 Mar 26;8(1):5220. doi: 10.1038/s41598-018-21463-1.

13.

New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies.

Meyer S, Evers M, Jansen JHM, Buijs J, Broek B, Reitsma SE, Moerer P, Amini M, Kretschmer A, Ten Broeke T, den Hartog MT, Rijke M, Klein C, Valerius T, Boross P, Leusen JHW.

Br J Haematol. 2018 Mar;180(6):808-820. doi: 10.1111/bjh.15132. Epub 2018 Feb 22.

PMID:
29468712
14.

Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe.

Honarvar H, Calce E, Doti N, Langella E, Orlova A, Buijs J, D'Amato V, Bianco R, Saviano M, Tolmachev V, De Luca S.

Sci Rep. 2018 Feb 14;8(1):2998. doi: 10.1038/s41598-018-21283-3.

15.

Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes.

Peeters SA, Engelen L, Buijs J, Theilade S, Rossing P, Schalkwijk CG, Stehouwer CDA.

J Diabetes Complications. 2018 Mar;32(3):325-329. doi: 10.1016/j.jdiacomp.2017.12.011. Epub 2018 Jan 3.

PMID:
29395841
16.

Novel Real-Time Proximity Assay for Characterizing Multiple Receptor Interactions on Living Cells.

Bondza S, Björkelund H, Nestor M, Andersson K, Buijs J.

Anal Chem. 2017 Dec 19;89(24):13212-13218. doi: 10.1021/acs.analchem.7b02983. Epub 2017 Dec 5.

PMID:
29160688
17.

Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m.

Garousi J, Lindbo S, Mitran B, Buijs J, Vorobyeva A, Orlova A, Tolmachev V, Hober S.

Sci Rep. 2017 Nov 7;7(1):14780. doi: 10.1038/s41598-017-15366-w.

18.

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Jorsal A, Parving HH, Tarnow L, Theilade S, Rossing P, Schalkwijk CG, Stehouwer CDA.

Cardiovasc Diabetol. 2017 Oct 25;16(1):139. doi: 10.1186/s12933-017-0620-9.

19.

Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label.

Lindbo S, Garousi J, Mitran B, Altai M, Buijs J, Orlova A, Hober S, Tolmachev V.

J Nucl Med. 2018 Jan;59(1):93-99. doi: 10.2967/jnumed.117.197202. Epub 2017 Sep 1.

20.

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule.

Garousi J, Andersson KG, Dam JH, Olsen BB, Mitran B, Orlova A, Buijs J, Ståhl S, Löfblom J, Thisgaard H, Tolmachev V.

Sci Rep. 2017 Jul 20;7(1):5961. doi: 10.1038/s41598-017-05700-7.

21.

The Value of 18F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever.

Kouijzer IJE, Kampschreur LM, Wever PC, Hoekstra C, van Kasteren MEE, de Jager-Leclercq MGL, Nabuurs-Franssen MH, Wegdam-Blans MCA, Ammerlaan HSM, Buijs J, Geus-Oei LF, Oyen WJG, Bleeker-Rovers CP.

J Nucl Med. 2018 Jan;59(1):127-133. doi: 10.2967/jnumed.117.192492. Epub 2017 May 25.

22.

Real-time Characterization of Antibody Binding to Receptors on Living Immune Cells.

Bondza S, Foy E, Brooks J, Andersson K, Robinson J, Richalet P, Buijs J.

Front Immunol. 2017 Apr 24;8:455. doi: 10.3389/fimmu.2017.00455. eCollection 2017.

23.

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.

Peeters SA, Engelen L, Buijs J, Jorsal A, Parving HH, Tarnow L, Rossing P, Schalkwijk CG, Stehouwer CDA.

Cardiovasc Diabetol. 2017 Apr 26;16(1):55. doi: 10.1186/s12933-017-0539-1.

24.

Murine models of breast cancer bone metastasis.

Wright LE, Ottewell PD, Rucci N, Peyruchaud O, Pagnotti GM, Chiechi A, Buijs JT, Sterling JA.

Bonekey Rep. 2016 May 11;5:804. eCollection 2016.

25.

Testing for Anti-PBP Antibody Is Not Useful in Diagnosing Autoimmune Pancreatitis.

Buijs J, Cahen DL, van Heerde MJ, Hansen BE, van Buuren HR, Peppelenbosch MP, Fuhler GM, Bruno MJ.

Am J Gastroenterol. 2016 Nov;111(11):1650-1654. doi: 10.1038/ajg.2016.241. Epub 2016 Jun 21.

PMID:
27325222
26.

Comparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IX.

Garousi J, Honarvar H, Andersson KG, Mitran B, Orlova A, Buijs J, Löfblom J, Frejd FY, Tolmachev V.

Mol Pharm. 2016 Nov 7;13(11):3676-3687. Epub 2016 Sep 27.

PMID:
27529191
27.

Surface plasmon resonance biosensing: Approaches for screening and characterising antibodies for food diagnostics.

Yakes BJ, Buijs J, Elliott CT, Campbell K.

Talanta. 2016 Aug 15;156-157:55-63. doi: 10.1016/j.talanta.2016.05.008. Epub 2016 May 3.

28.

The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke.

Buijs JE, Uyttenboogaart M, Brouns R, de Keyser J, Kamphuisen PW, Luijckx GJ.

J Stroke Cerebrovasc Dis. 2016 Feb;25(2):312-6. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.035. Epub 2015 Oct 30.

PMID:
26527412
29.

Reply to Saliou et al.

Verfaillie CJ, Bruno MJ, Voor In 't Holt AF, Buijs JG, Poley JW, Loeve AJ, Severin JA, Abel LF, Smit BJ, de Goeij I, Vos MC.

Endoscopy. 2015 Nov;47(11):1059. doi: 10.1055/s-0034-1392802. Epub 2015 Oct 30. No abstract available.

PMID:
26517740
30.

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.

Kroon J, Puhr M, Buijs JT, van der Horst G, Hemmer DM, Marijt KA, Hwang MS, Masood M, Grimm S, Storm G, Metselaar JM, Meijer OC, Culig Z, van der Pluijm G.

Endocr Relat Cancer. 2016 Jan;23(1):35-45. doi: 10.1530/ERC-15-0343. Epub 2015 Oct 19.

31.

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Cardiovasc Diabetol. 2015 Sep 28;14:128. doi: 10.1186/s12933-015-0290-4. No abstract available.

32.

Winter Activity and Aboveground Hybridization Between the Two Biotypes of the West Nile Virus Vector Culex pipiens.

Vogels CB, van de Peppel LJ, van Vliet AJ, Westenberg M, Ibañez-Justicia A, Stroo A, Buijs JA, Visser TM, Koenraadt CJ.

Vector Borne Zoonotic Dis. 2015 Oct;15(10):619-26. doi: 10.1089/vbz.2015.1820. Epub 2015 Sep 22.

PMID:
26394124
33.

The Long-Term Impact of Autoimmune Pancreatitis on Pancreatic Function, Quality of Life, and Life Expectancy.

Buijs J, Cahen DL, van Heerde MJ, Rauws EA, de Buy Wenniger LJ, Hansen BE, Biermann K, Verheij J, Vleggaar FP, Brink MA, Beuers UH, van Buuren HR, Bruno MJ.

Pancreas. 2015 Oct;44(7):1065-71. doi: 10.1097/MPA.0000000000000451.

PMID:
26355549
34.

ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers.

Garousi J, Lindbo S, Nilvebrant J, Åstrand M, Buijs J, Sandström M, Honarvar H, Orlova A, Tolmachev V, Hober S.

Cancer Res. 2015 Oct 15;75(20):4364-71. doi: 10.1158/0008-5472.CAN-14-3497. Epub 2015 Aug 21.

35.

First Draft Genome Sequence of a Human Coxiella burnetii Isolate, Originating from the Largest Q Fever Outbreak Ever Reported, the Netherlands, 2007 to 2010.

Hammerl JA, Mertens K, Sprague LD, Hackert VH, Buijs J, Hoebe CJ, Henning K, Neubauer H, Al Dahouk S.

Genome Announc. 2015 May 7;3(3). pii: e00445-15. doi: 10.1128/genomeA.00445-15.

36.

Withdrawal of a novel-design duodenoscope ends outbreak of a VIM-2-producing Pseudomonas aeruginosa.

Verfaillie CJ, Bruno MJ, Voor in 't Holt AF, Buijs JG, Poley JW, Loeve AJ, Severin JA, Abel LF, Smit BJ, de Goeij I, Vos MC.

Endoscopy. 2015 Jun;47(6):502. doi: 10.1055/s-0034-1392080. Epub 2015 Apr 27. No abstract available.

PMID:
25915397
37.

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Cardiovasc Diabetol. 2015 Mar 10;14:31. doi: 10.1186/s12933-015-0195-2. Erratum in: Cardiovasc Diabetol. 2015;14:128.

38.

Withdrawal of a novel-design duodenoscope ends outbreak of a VIM-2-producing Pseudomonas aeruginosa.

Verfaillie CJ, Bruno MJ, Voor in 't Holt AF, Buijs JG, Poley JW, Loeve AJ, Severin JA, Abel LF, Smit BJ, de Goeij I, Vos MC.

Endoscopy. 2015 Jun;47(6):493-502. doi: 10.1055/s-0034-1391886. Epub 2015 Mar 31. Erratum in: Endoscopy. 2015 Jun;47(6):502.

PMID:
25826278
39.

Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.

Kroon J, Buijs JT, van der Horst G, Cheung H, van der Mark M, van Bloois L, Rizzo LY, Lammers T, Pelger RC, Storm G, van der Pluijm G, Metselaar JM.

Prostate. 2015 Jun;75(8):815-24. doi: 10.1002/pros.22963. Epub 2015 Feb 8.

40.

Single-Limb Irradiation Induces Local and Systemic Bone Loss in a Murine Model.

Wright LE, Buijs JT, Kim HS, Coats LE, Scheidler AM, John SK, She Y, Murthy S, Ma N, Chin-Sinex HJ, Bellido TM, Bateman TA, Mendonca MS, Mohammad KS, Guise TA.

J Bone Miner Res. 2015 Jul;30(7):1268-79. doi: 10.1002/jbmr.2458. Epub 2015 Jun 8.

41.

Predicting tick presence by environmental risk mapping.

Swart A, Ibañez-Justicia A, Buijs J, van Wieren SE, Hofmeester TR, Sprong H, Takumi K.

Front Public Health. 2014 Nov 26;2:238. doi: 10.3389/fpubh.2014.00238. eCollection 2014.

42.

Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase.

Buijs JT, Matula KM, Cheung H, Kruithof-de Julio M, van der Mark MH, Snoeks TJ, Cohen R, Corver WE, Mohammad KS, Jonkers J, Guise TA, van der Pluijm G.

J Pathol. 2015 Apr;235(5):745-59. doi: 10.1002/path.4488. Epub 2015 Jan 23.

43.

Brown adipose tissue takes up plasma triglycerides mostly after lipolysis.

Khedoe PP, Hoeke G, Kooijman S, Dijk W, Buijs JT, Kersten S, Havekes LM, Hiemstra PS, Berbée JF, Boon MR, Rensen PC.

J Lipid Res. 2015 Jan;56(1):51-9. doi: 10.1194/jlr.M052746. Epub 2014 Oct 28.

44.

Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.

Kroon J, in 't Veld LS, Buijs JT, Cheung H, van der Horst G, van der Pluijm G.

Oncotarget. 2014 Oct 15;5(19):8986-94.

45.

Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness.

Wissing MD, De Morrée ES, Dezentjé VO, Buijs JT, De Krijger RR, Smit VT, Van Weerden WM, Gelderblom H, van der Pluijm G.

Oncotarget. 2014 Sep 15;5(17):7357-67.

46.

The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial--BARTrial.

Hulzebos CV, Dijk PH, van Imhoff DE, Bos AF, Lopriore E, Offringa M, Ruiter SA, van Braeckel KN, Krabbe PF, Quik EH, van Toledo-Eppinga L, Nuytemans DH, van Wassenaer-Leemhuis AG, Benders MJ, Korbeeck-van Hof KK, van Lingen RA, Groot Jebbink LJ, Liem D, Mansvelt P, Buijs J, Govaert P, van Vliet I, Mulder TL, Wolfs C, Fetter WP, Laarman C; BARTrial Study Group.

PLoS One. 2014 Jun 13;9(6):e99466. doi: 10.1371/journal.pone.0099466. eCollection 2014.

47.

Automated functional characterization of radiolabeled antibodies: a time-resolved approach.

Wang E, Björkelund H, Mihaylova D, Hagemann UB, Karlsson J, Malmqvist M, Buijs J, Abrahmsén L, Andersson K.

Nucl Med Commun. 2014 Jul;35(7):767-76. doi: 10.1097/MNM.0000000000000117.

PMID:
24709981
48.

A comparative study of diagnostic scoring systems for autoimmune pancreatitis.

van Heerde MJ, Buijs J, Rauws EA, de Buy Wenniger LJ, Hansen BE, Biermann K, Verheij J, Vleggaar FP, Brink MA, Beuers UH, Kuipers EJ, van Buuren HR, Bruno MJ.

Pancreas. 2014 May;43(4):559-64. doi: 10.1097/MPA.0000000000000045.

PMID:
24658319
49.

Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database.

Kampschreur LM, Delsing CE, Groenwold RH, Wegdam-Blans MC, Bleeker-Rovers CP, de Jager-Leclercq MG, Hoepelman AI, van Kasteren ME, Buijs J, Renders NH, Nabuurs-Franssen MH, Oosterheert JJ, Wever PC.

J Clin Microbiol. 2014 May;52(5):1637-43. doi: 10.1128/JCM.03221-13. Epub 2014 Mar 5.

50.

Immunoglobulin G4-related prostatitis: a case-control study focusing on clinical and pathologic characteristics.

Buijs J, Maillette de Buy Wenniger L, van Leenders G, Verheij J, van Onna I, Hansen B, van Heerde M, Krak N, Beuers U, Bruno M, van Buuren H.

Urology. 2014 Mar;83(3):521-6. doi: 10.1016/j.urology.2013.10.052.

PMID:
24581512

Supplemental Content

Support Center